JPS60114768A - Full-automatic blood analyser - Google Patents

Full-automatic blood analyser

Info

Publication number
JPS60114768A
JPS60114768A JP22286783A JP22286783A JPS60114768A JP S60114768 A JPS60114768 A JP S60114768A JP 22286783 A JP22286783 A JP 22286783A JP 22286783 A JP22286783 A JP 22286783A JP S60114768 A JPS60114768 A JP S60114768A
Authority
JP
Japan
Prior art keywords
sample
analysis
blood
whole blood
identification code
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP22286783A
Other languages
Japanese (ja)
Other versions
JPH0695095B2 (en
Inventor
Shojiro Hashizume
橋詰　昭次郎
Takashi Kawamoto
川本　孝
Katsuo Fukuda
福田　克雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Shimazu Seisakusho KK
Original Assignee
Shimadzu Corp
Shimazu Seisakusho KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp, Shimazu Seisakusho KK filed Critical Shimadzu Corp
Priority to JP58222867A priority Critical patent/JPH0695095B2/en
Publication of JPS60114768A publication Critical patent/JPS60114768A/en
Publication of JPH0695095B2 publication Critical patent/JPH0695095B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

PURPOSE:To obtain an apparatus capable of automatically performing analysis to a whole blood specimen and analysis to a clarified solution, by providing a means for inputting the discrimination code and analytical items of the specimen and a means for obtaining analyzed data by operating and controlling a whole blood analyser corresponding to the analytical items. CONSTITUTION:CPU9 judges whether a specimen of a discrimination code reguires analysis on the basis of the information form a discrimination code reader 11 and the information from a card reader 7. When analysis is required, a sampler 16 is operated and the specimen container 2 thereof is introduced into an analytical means 21 where the specimen is distributed to perform analysis. Subsequently, when the specimen requires analysis in a clarified solution analytical means 23 on the basis of the informations from a discrimination code reader 12 and the card reader 7, the specimen container 2 is introduced into a blood separating means 22 by a sampler 17 and the separation of the clarified solution from whole blood is performed. When the container 2 having the clarified solution received therein is detected by a reader 13, a sampler 18 is operated and the container 2 is introduced into the analytical means 23 to perform analysis. Analyzed results of whole blood and the clarified solution thus obtained are printed out by a printer 29.

Description

【発明の詳細な説明】 （イ）産業上の利用分野 この発明は、全血の検体を自動分析する全自動血液分析
装　置に関し、特に臨床検査システムとして有用である
。Detailed Description of the Invention (a) Industrial Application Field The present invention relates to a fully automated blood analyzer that automatically analyzes whole blood samples, and is particularly useful as a clinical testing system.

（ロ）従来技術 血液の分析は、大別すると、全血の検体を分析対象とす
る分析と、全血に含まれる有形成分を除去した清澄液の
検体を分析対象とする分析とに分れ、これに応じて分析
装置も前者に属するものと後者に属するものとに分れて
いる。(B) Conventional technology Blood analysis can be roughly divided into analysis that uses whole blood samples as the analysis target, and analysis that uses clear fluid samples from which formed components contained in whole blood have been removed. Accordingly, analytical devices are divided into those that belong to the former category and those that belong to the latter category.

そこで従来は一般的には全血分析手段と清澄液分析手段
を用いる場合には全血の検体と遠心分離などで浮遊成分
を除去した清澄液の検体を得て、これらを各々に対応す
る分析装置の検体容器にあらかじめ分割分配し、分析装
置ごとに検体番号を設けて該当する分析装置に別個にセ
ットしていた。Conventionally, when using whole blood analysis means and clarified liquid analysis means, the conventional method is to obtain a whole blood sample and a clarified liquid sample from which suspended components have been removed by centrifugation, etc., and perform the respective analyzes on these samples. The sample was divided and distributed in advance into the sample containers of the device, a sample number was assigned to each analyzer, and the sample was set separately in the corresponding analyzer.

しかし、これによればオペレータの負担が大きく処理効
率が低く、また検体を二つ以上に分けるため！ｌｃｌ；
ｌｌ別コードが二通り以上になって識別コードの混乱に
よるミスを発生しゃすい問題があった。However, this method imposes a large burden on the operator and has low processing efficiency, and also requires separating the sample into two or more! lcl;
There was a problem in that there were two or more different identification codes, making it easy for mistakes to occur due to confusion in the identification codes.

このようなミスは本来発生してはならないミスであるが
、０．３％程度の発生があるといわれている。Although such mistakes should not occur, it is said that they occur at a rate of about 0.3%.

全血分析手段と血液分離手段と清澄液分析手段とを具備
したシステムが例えば特開昭５８−１４０６４４号など
提案されているが、検体を各分析装置に配分する方式な
どの点で満足できる程度まで完成されたものではない。A system equipped with a whole blood analysis means, a blood separation means, and a clear liquid analysis means has been proposed, for example, in Japanese Patent Application Laid-Open No. 140644/1983, but it is not satisfactory in terms of the method of distributing the sample to each analyzer. It has not yet been completed.

（ノリ発明の目的 この発明は、オペレータが全血の検体をセットするだけ
で全血の検体に対する分析と清澄液に対する分析とを自
動的に全て行い得る全自動の血液分析装置を提供するこ
とを目的とするものである。(Purpose of the invention) The present invention aims to provide a fully automatic blood analyzer that can automatically perform all analyzes on whole blood samples and clear fluids simply by setting a whole blood sample by an operator. This is the purpose.

（ニ）発明の構成 この発明の全自動血液分析装置は、 （ａ）　全血を検体として収容しかつ識別コードを付さ
れうる多数の検体容器、 （ｂ）　それら検体容器を移送ラインに沿って移送する
移送手段、 （０）　上記移送ラインに少なくとも１台設置される識
別コード読取器、 （ω　上記移送ラインの先頭の識別コード読取器以後に
設置され、移送ライン上の検体容器から検体を分取する
ための分取手段と、分取した全血の検体よシ成分濃度や
血球数や血液凝固因子や細胞のような浮遊成分等の分析
項目の少なくとも１つを分析する全血分析手段とを有す
る全血分析装置、（ｅ）　上記全血分析装置の後に設置
され、移送ライン上の検体容器から検体を分取するため
の分取手段と、分取した全血の検体中の浮遊成分を除去
して清澄液を得る血液分離手段と、分離した清澄液を移
送ライン上の検体容器に収容する収容手段とを有する血
液分ｍ装置、 （ｆ）　上記血液分離装置の後に設置され、移送ライン
上の検体容器から清澄液を分取するための分取手段と、
上記清澄液を検体としてその成分濃度や物理量などの分
析項目の少なくとも１つを分析する清澄液分析手段とを
有する清澄液分析装置、および （ｇ）　検体の識別コードおよびその検体に適用すべき
分析項目を入力される分析項目入力手段と、前記識別コ
ード読取器で検体容器の識別コードを読みとった後その
識別コードの検体に適用すべき分析項目に応じて前記全
血分析装置と血液分離装置と清澄液分離装置を適切に作
動側り１１シて分析データを得るデータ処理手段と、得
られた分析データを出力するデータ出力手段とを有する
コンピュータ装置 を具備して構成される。(d) Structure of the Invention The fully automatic blood analyzer of the present invention includes (a) a large number of sample containers that contain whole blood as a sample and can be assigned identification codes; (b) the sample containers are moved along a transfer line. A transfer means for transferring, (0) at least one identification code reader installed on the transfer line, (ω installed after the identification code reader at the beginning of the transfer line, separating the sample from the sample container on the transfer line); and a whole blood analysis means for analyzing at least one of analysis items such as component concentration, blood cell count, blood coagulation factors, and suspended components such as cells from the sample of the fractionated whole blood. (e) a fractionating means installed after the whole blood analyzer for fractionating the specimen from the specimen container on the transfer line; and a floating component in the fractionated whole blood specimen. a blood separation device having a blood separation means for removing the clarified liquid to obtain a clarified liquid; and a storage means for storing the separated clarified liquid in a sample container on a transfer line; a fractionating means for fractionating a clear liquid from a sample container on the line;
a clear liquid analyzer having a clear liquid analysis means for analyzing at least one of the analysis items such as component concentration and physical quantity using the above-mentioned clear liquid as a sample; and (g) an identification code of the sample and analysis to be applied to the sample. analysis item input means for inputting items, and the whole blood analyzer and blood separation device according to the analysis item to be applied to the sample with the identification code after reading the identification code of the sample container with the identification code reader. It is constructed by comprising a computer device having data processing means for appropriately operating the clarified liquid separator to obtain analytical data, and data output means for outputting the obtained analytical data.

上記全血分析手段には、例えば血球計数装置。The whole blood analysis means includes, for example, a blood cell counter.

血球画像解析装置、血中ガス分析装置、電解質測定イオ
ンメータがある。There are blood cell image analyzers, blood gas analyzers, and electrolyte measurement ion meters.

上記血液分離手段には、例えば半透膜を用いるものがあ
る。Some of the blood separation means described above use, for example, a semipermeable membrane.

上記清澄液分析手段には、例えば生化学分析装置゛、免
疫学分析装置がある。Examples of the clear liquid analysis means include a biochemical analyzer and an immunological analyzer.

（ホ）実施例 第１図に示す（１）は、この発明の全自動血液分析装置
の一実施例である。(E) Embodiment (1) shown in FIG. 1 is an embodiment of the fully automated blood analyzer of the present invention.

オペレータは、第２図に示すように、検体容器Ｑ）のホ
ルダー翰に保持された全血管（３）に全血の検体を入れ
、それに識別コードをマークしたラベル（４）を付け、
かつ清澄液管（５）は空のままとし、その検体容器（２
）を検体容器供給ステーション（６）にセットする。さ
らにその識別コードと適用すべき分析項目とをカードに
マークし、そのカードをカードリーダ（７）にセットす
る。分析するべき多数の全血の検体について同じことを
行ない、次いで操作卓（８）からコンピュータ（９）に
分析作動の開始を指示するＯ コンピュータ（９）はチェーン・コンベヤの如キ移送手
段四を制御し、その移送手段ａ０は検体容器（２）を順
に移送ラインに送り出す。As shown in Fig. 2, the operator puts a whole blood sample into the whole blood vessel (3) held in the holder of the sample container Q), attaches a label (4) with an identification code to it, and
In addition, leave the clear liquid tube (5) empty and remove the sample container (2).
) in the sample container supply station (6). Furthermore, the identification code and the analysis items to be applied are marked on a card, and the card is set in the card reader (7). The same thing is done for a number of whole blood samples to be analyzed, and then the operator console (8) instructs the computer (9) to start the analysis operation. The transfer means a0 sequentially sends out the sample containers (2) to the transfer line.

コンピュータ（９）は、移送手段（１（１で送られてき
た検体容器（２）の識別コードを識別コード読取器（ロ
）により読取ると、その識別コードの検体が全血分析手
段Ｑυで分析することヲ要するか否かをカードリーダ（
７）からの情報で判断し、分析を要する場合にはサンプ
ラー（ト）を作動制御してその検体容器Ｑ）を取り上げ
て全血分析子［０υに導入し、ここでピペッタなどで検
体を分取して分析を行なわせる。全血分析手段ｅ心は、
例えば公知の血球面数装置である。一方、分析を要しな
い場合には何もしないで通過させる。When the computer (9) reads the identification code of the sample container (2) sent by the transfer means (1) with an identification code reader (b), the sample with that identification code is analyzed by the whole blood analysis means Qυ. Check the card reader (
Judging from the information from 7), if analysis is required, operate the sampler (G), pick up the sample container Q), introduce it into the whole blood analyzer [0υ, and separate the sample using a pipettor etc. and have it analyzed. Whole blood analysis means e heart is
For example, it is a known blood cell count device. On the other hand, if no analysis is required, it is passed without doing anything.

次いで、識別コード読取機（ロ）からの情報とカードリ
ーダ（７）からの情報によって、その識別コードの検体
が清澄液分析手段■で分析することを要するか否かを判
断し、分析を要しない場合には何もしないで通過させる
が、分析を要する場合にはサンプラーＱηを作動制御し
１その検体容器（２）を取り上げて血液分離手段（２）
に導入し、全血の検体から清澄液の分離を行なわせる。Next, based on the information from the identification code reader (b) and the information from the card reader (7), it is determined whether the sample with the identification code requires analysis using the clear liquid analysis means (■), and the analysis is performed. If not, it is passed without doing anything, but if analysis is required, the sampler Qη is operated and the sample container (2) is taken up and the blood separation means (2)
The clear liquid is separated from the whole blood sample.

血液分離手段（イ）は、第３図に示すように、全血の検
体御を入れた全血管（３）　Ｋ　、セルロースアセテー
ト膜のような分離膜０υを外面に有する網管に）を挿入
し、その網管に）の内部をポンプ（ト）で負圧にするこ
とによって、清澄液（ロ）のみを内部に透過させるもの
である。得られた清澄液（ロ）は検体容器（２）の清澄
液管（５）Ｋ入れられ、そののち検体容器（２）はサン
プラーぐので移送手段叫上に戻される。As shown in Fig. 3, the blood separation means (a) consists of inserting a whole blood vessel (3) containing a whole blood specimen into a mesh tube having a separation membrane such as a cellulose acetate membrane on the outer surface. , into the net pipe) by creating a negative pressure inside it with a pump (g), allowing only the clarified liquid (b) to permeate inside. The obtained clarified liquid (b) is put into the clarified liquid tube (5)K of the specimen container (2), and then the specimen container (2) is returned to the sampler and transferred onto the transfer means.

コンピュータ（９）は、清澄液を入れられた検体容器（
２）が識別コード読取機ａ）で検知されると、サンプラ
ー（へ）を作動して、その検体容器（２）を清澄液分析
手段に）に導入し、分析を行わせる。清澄液分析手段（
ホ）は、たとえば公知の生化学分析装置である。The computer (9) is connected to a sample container (
When 2) is detected by the identification code reader a), the sampler is activated to introduce the sample container (2) into the clear liquid analysis means for analysis. Clear liquid analysis means (
E) is, for example, a known biochemical analyzer.

一方、清澄液を入れられた検体容器（２）以外の検体容
器は何もしないで通過させる。On the other hand, the sample containers other than the sample container (2) containing the clarified liquid are allowed to pass through without doing anything.

上記で得られた全血および／または清澄７１更の分析結
果は、プリンタ翰に打ち出される。The whole blood and/or clarified 71 further analysis results obtained above are printed on a printer.

さらにコンピュータ（９）は、識別コード読取機（１４
１からの情報とカードリーダ（７）からの情報と全血お
よび／または清澄液の分析結果によって、その識別コー
ドの検体が用手法分析で分析することを要するものであ
るか否かを判断し、分析を要しない場合には伺もしない
で通過させるが、分析を要する場合にはサンプラーｑ翅
およびコンベヤ（ハ）を作動制御してその検体容器（２
）　ｉ取り上げて用手法分析ステーションいψに導入し
、用手法分析を可能とする０ また同様に、識別コード読取機Ｍからの情報とカードリ
ーダ（７）からの情報と全血および／または清澄液の分
析結果によって、その識別コードの検体が再検査を要す
るものでおるか否かを判断し、再検査を要しない場合に
は何もしないで通過させるが、分析を要する場合にはサ
ンプラ一体）およびコンベヤに）を作動制御してその検
体容器（２）を取り上げて再検査ステーションシフ）Ｋ
導入し、再検査を可能とする。Further, the computer (9) has an identification code reader (14).
Based on the information from 1, the information from the card reader (7), and the analysis results of whole blood and/or clarified fluid, it is determined whether the specimen with the identification code requires analysis by manual analysis. , If analysis is not required, the sample container (2) is passed through without asking, but if analysis is required, the operation of the sampler (1) and the conveyor (3) is controlled to remove the sample container (2).
) i and introduce it into the manual analysis station ψ to enable manual analysis 0 Similarly, information from the identification code reader M, information from the card reader (7), whole blood and/or clarified Based on the analysis results of the liquid, it is determined whether or not the sample with that identification code requires retesting.If retesting is not required, it is passed without doing anything, but if analysis is required, the sampler is integrated. ) and conveyor) to pick up the sample container (2) and shift the retesting station) K
This will enable re-examination.

用手法分析ステーション（２）または再検査ステーショ
ン＠に移されなかった検体容器（２）は、保存または貯
蔵ステーションに）に移送され、収納されるＯ変形実施
例としては、識別コード読取器（ロ）だけを備えており
、他の識別コード読取器０４〜θＱが単なる位置センサ
ーに代えられたものを挙げられる０第４図に示す（２）
は、検体容器の他の一例である。Specimen containers (2) that have not been transferred to the manual analysis station (2) or the retesting station are transferred to and stored in the storage or storage station. ), and other identification code readers 04 to θQ are replaced with mere position sensors, as shown in Figure 4 (2).
is another example of a sample container.

（３つは全血管、（４つは識別コードのラベル、６つは
清澄液管、（２９ｍホルダー、輪は希釈検体管である。(3 are whole blood vessels, (4 are labels with identification codes, 6 are clear liquid tubes, (29m holder, and the rings are diluted sample tubes.

この希釈検体管…は、再検査のときに所定倍率に希釈し
た検体を入れておくの【で用いる。This diluted sample tube is used to store a sample diluted to a predetermined ratio during reexamination.

さらに他の検体容器の例としては、全血管を２種類具備
し、ヘパリン処理した全血検体とｍＤＴＡ処理した全血
検体の両方を入れられるようにしたものを挙げられる。Another example of a sample container is one that is equipped with two types of whole blood vessels and is capable of containing both a heparin-treated whole blood sample and an mDTA-treated whole blood sample.

（へ）発明の効果 この発明の全自動血液分析装置によれば、全血の検体を
その捷ま装置にセットするだけで全血の検体に対する分
析と清澄液の検体に対する分析とが全て自動的に行われ
うるから、オペレータが全血の試料から清澄液を分離す
る必要がなくなって負担が軽減されると共に、分析の効
率が向上して多数の検体でも短時間で処理できるように
なる。(F) Effects of the Invention According to the fully automatic blood analyzer of the present invention, analysis of whole blood samples and clear liquid samples can be performed automatically by simply setting a whole blood sample in the straining device. This eliminates the need for the operator to separate a clear fluid from a whole blood sample, reducing the burden on the operator, and improves analysis efficiency, allowing a large number of samples to be processed in a short time.

また、セットする検体の一個につき一個の識別コードを
対応させればよいことになるから、識別コードの誤りが
少なくなって信頼性を向上できる。Furthermore, since it is only necessary to associate one identification code with each specimen to be set, errors in identification codes are reduced and reliability can be improved.

尚、この発明の装Ｗは、通常は上記のように血液を分析
するのに用いられるが、所望により尿や髄液などの体液
の分析にも用いることができる。The device W of the present invention is normally used to analyze blood as described above, but it can also be used to analyze body fluids such as urine and spinal fluid if desired.

【図面の簡単な説明】 第１図はこの発明の全自動血液分析装置の一実施例の構
成説明図、第２図は第１図に示す装置における検体容器
の斜視図、第３図は第１図に示す装置における血液分離
手段の作動説明図、第４図はこの発明の全自動血液分析
装置の検体容器の他の一例の斜視図である。 （１）・・・・・・全自動血液分析装置１イ、（２）・
・−・・・検体容器、　（３１・・・・・・全血管、（
４）・・・・・・識別コードのラベル、（５）・・・・
・・清澄液管、　（７）・・・・・・カードリーグ、（
８）・・・・・・操作卓、（９）・・・・コンピュータ
、αＱ・・・・・・移送手段、 （ロ）〜Ｑω・・・・・・識別コード読取器、へ（イ）
〜翰・・・・・・サングラ−１Ｑυ・・・・・・全血分
析装置、■　・・・血液分離装置、　（イ）・・・・・
・清澄液分析装置、い少・・・・・・プリンタ。 代理人　弁理士　野　河　信太部[BRIEF DESCRIPTION OF THE DRAWINGS] FIG. 1 is an explanatory diagram of the configuration of an embodiment of the fully automatic blood analyzer of the present invention, FIG. 2 is a perspective view of a sample container in the device shown in FIG. 1, and FIG. FIG. 4 is a perspective view of another example of the sample container of the fully automatic blood analyzer of the present invention. (1)...Fully automatic blood analyzer 1a, (2)...
・−・・Specimen container, (31・・・・All blood vessels, (
4)...Identification code label, (5)...
... Clear liquid tube, (7) ... Card league, (
8)...Operation console, (9)...Computer, αQ...Transfer means, (B) ~Qω...Identification code reader, (B)
〜翰・・・Sangler-1Qυ・・・Whole blood analyzer,■・・・Blood separation device, (A)・・・・・・
・Clear liquid analyzer, small printer. Agent Patent Attorney Shintabe Nogawa

Claims (1)

【特許請求の範囲】 Ｌ　（ａ）　全血を検体として収容しかつ識別コードを
付されうる多数の検体容器、 （ｂ）　それら検体容器を移送ラインに沿って移送する
移送手段、 （ｃ）　上記移送ラインに少なくとも１台設置される識
別コード読取器、 （、ｉ）　上記移送ラインの先頭の識別コード読取器以
後に設置され、移送ライン上の検体容器から検体を分取
するための分取手段と、分取した全血の検体より成分濃
度や血球数や血液凝固因子や浮遊成分などの分析項目の
少なくとも１つを分析する全血分析手段とを有する全血
分析装置、（ｅ）　上記全血分析装置の後に設置され、
移送ライン上の検体容器から検体を分取するための分取
手段と、分取した全血の検体中の浮遊成分を除去して清
澄液を得る血液分離手段と、分離こた清澄液を移送ライ
ン上の検体容器に収容する収容手段とを有する血液分離
装置、 （ｆ）　上記血液分離装置の後に設置され、移送ライン
上の検体容器から清澄液を分取するための分取手段と、
上記清澄液を検体としてその・成分濃度や物理量などの
分析項目の少なくとも１つを分析する清澄液分析手段と
を有する清澄液分析装置、および （ｇ）　検体の識別コードおよびその検体に適用すべき
分析項目を入力される分析項目入力手段と、前記識別コ
ード読取器で検体容器の識別コードを読みとった後その
識別コードの検体に適用すべき分析項目に応じて前記全
血分析装置と血液分離装置と清澄液分離装置を適切に作
動制御して分析データを得るデータ処理手段と、得られ
た分析データを出力するデータ出力手段とを有するコン
ピュータ装置 から構成される全自動血液分析装置。[Scope of Claims] L (a) a large number of sample containers containing whole blood as a sample and to which an identification code can be attached; (b) a transfer means for transferring the sample containers along a transfer line; (c) the above. at least one identification code reader installed on the transfer line; (i) a sorting means installed after the identification code reader at the beginning of the transfer line for separating the sample from the sample container on the transfer line; and a whole blood analysis device for analyzing at least one of analysis items such as component concentration, blood cell count, blood coagulation factors, and suspended components from the fractionated whole blood sample, (e) all of the above-mentioned installed after the blood analyzer,
A separation means for separating a sample from a sample container on a transfer line, a blood separation means for removing floating components in the separated whole blood sample to obtain a clear liquid, and a separating kotter to transfer the clear liquid. (f) a blood separation device having a storage means for accommodating the sample container on the transfer line;
A clear liquid analyzer having a clear liquid analysis means for analyzing at least one of the analysis items such as component concentration and physical quantity using the above-mentioned clear liquid as a sample, and (g) an identification code of the sample and a code to be applied to the sample. an analysis item input means for inputting an analysis item, and the whole blood analyzer and blood separation device according to the analysis item to be applied to the sample with the identification code after reading the identification code of the sample container with the identification code reader. A fully automatic blood analyzer comprising a computer device having a data processing means for appropriately controlling the operation of a clear liquid separation device to obtain analysis data, and a data output means for outputting the obtained analysis data.
JP58222867A 1983-11-25 1983-11-25 Fully automatic blood analyzer Expired - Lifetime JPH0695095B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58222867A JPH0695095B2 (en) 1983-11-25 1983-11-25 Fully automatic blood analyzer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58222867A JPH0695095B2 (en) 1983-11-25 1983-11-25 Fully automatic blood analyzer

Publications (2)

Publication Number Publication Date
JPS60114768A true JPS60114768A (en) 1985-06-21
JPH0695095B2 JPH0695095B2 (en) 1994-11-24

Family

ID=16789129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58222867A Expired - Lifetime JPH0695095B2 (en) 1983-11-25 1983-11-25 Fully automatic blood analyzer

Country Status (1)

Country Link
JP (1) JPH0695095B2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6262261U (en) * 1985-10-05 1987-04-17
JPS62115363A (en) * 1985-11-14 1987-05-27 Nitsuteku:Kk Method and apparatus for processing blood information
JPS6283964U (en) * 1985-11-14 1987-05-28
JPS62232570A (en) * 1986-04-02 1987-10-13 Nittec Co Ltd Method and apparatus for transferring specimen container
JPS6385457A (en) * 1986-09-30 1988-04-15 Shimadzu Corp Automatic analyzer for plural items
JPS63236966A (en) * 1987-03-25 1988-10-03 Shimadzu Corp Automatic sample conveying device
JPH02146369U (en) * 1989-05-17 1990-12-12
US5209903A (en) * 1989-09-06 1993-05-11 Toa Medical Electronics, Co., Ltd. Synthetic apparatus for inspection of blood
US6101449A (en) * 1995-06-07 2000-08-08 Akzo Nobel N.V. Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US7211438B2 (en) 1999-02-04 2007-05-01 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58628A (en) * 1981-06-01 1983-01-05 グレンツア−・スピ−セル Uniform velocity rotary three-leg joint

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58628A (en) * 1981-06-01 1983-01-05 グレンツア−・スピ−セル Uniform velocity rotary three-leg joint

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6262261U (en) * 1985-10-05 1987-04-17
JPH0543063B2 (en) * 1985-11-14 1993-06-30 Nittec Co Ltd
JPS62115363A (en) * 1985-11-14 1987-05-27 Nitsuteku:Kk Method and apparatus for processing blood information
JPS6283964U (en) * 1985-11-14 1987-05-28
JPS62232570A (en) * 1986-04-02 1987-10-13 Nittec Co Ltd Method and apparatus for transferring specimen container
JPS6385457A (en) * 1986-09-30 1988-04-15 Shimadzu Corp Automatic analyzer for plural items
JPS63236966A (en) * 1987-03-25 1988-10-03 Shimadzu Corp Automatic sample conveying device
JPH02146369U (en) * 1989-05-17 1990-12-12
US5209903A (en) * 1989-09-06 1993-05-11 Toa Medical Electronics, Co., Ltd. Synthetic apparatus for inspection of blood
US6101449A (en) * 1995-06-07 2000-08-08 Akzo Nobel N.V. Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays
US6269313B1 (en) 1995-06-07 2001-07-31 Akzo Nobel N.V. Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6564153B2 (en) 1995-06-07 2003-05-13 Biomerieux Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US7211438B2 (en) 1999-02-04 2007-05-01 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality

Also Published As

Publication number Publication date
JPH0695095B2 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
US6776961B2 (en) Workstation for integrating automated chemical analyzers
JP6018406B2 (en) Operation method of automatic sample work cell
EP2296819B1 (en) Centrifuge loading process within an automated laboratory system
JPS60114768A (en) Full-automatic blood analyser
JPS58154662A (en) Automatic analyzer
EP2804002B1 (en) Laboratory automated system with common sample buffer module
JPH04127063A (en) Apparatus for distributing specimen for clinical examination
JP2002040034A (en) Specimen sorting device
JP7227948B2 (en) Techniques for checking the condition of analyzers
US20240183872A1 (en) Diagnostic instruments having sorting capability and sorting methods thereof
CN102103146A (en) System and process for analyzing liquid sample
WO2008050397A1 (en) Analyzer
JP2016156675A (en) Automatic analysis device and analysis method
US20190310277A1 (en) Laboratory analysis system with improved sample pipetting
JPH0572212A (en) Automatic analytical apapratus
JPH03172764A (en) Automatic analysis apparatus
CN114636830A (en) Sample analysis apparatus, system and test method thereof
JP4557995B2 (en) Automatic analyzer
US20240019454A1 (en) Integrated automated analyzer and methods of analyzing whole blood and plasma from a single sample tube
JPH0287070A (en) Automatic apparatus for chemical analysis
JPS6049258B2 (en) Sample sorter in automatic analyzer
CN112345778B (en) Cascade sample analysis system, device and quality control project out-of-control processing method
JPS5813863B2 (en) Automatic dispensing analysis system
JPH0323868B2 (en)
JP2001264338A (en) Specimen pretreating system